GLYCOMET GP 0.5 MG TAB

1. All Details: Specifications
Dosage Form: Uncoated bilayered tablet.
Storage Instructions: Store in a cool, dry place. Protect from light.
Batch Number (BATCH No.): 60002570
Manufacturing Date (MFG. DATE): 01/2026
Expiry Date (EXPIRY DATE): 12/2027
Manufacturing License Number: Mfg. Lic. No.: G/25/2569
Maximum Retail Price (M.R.P.): Rs. 88.88 per 15 tablets (Inclusive of all taxes).
Internal Material Identifiers: 3018709
2. General
Brand: Glycomet-GP 0.5 (also printed in Devanagari script as ग्लाइकोमेट-जीपी ०.५).
Generic Name: Metformin Hydrochloride Prolonged-Release and Glimepiride Tablets IP
Quantity: 15 Tablets (indicated by “15 Tablets” and “FOR 15 TABS.”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the statutory Schedule G and Schedule H red caution warning labels).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: 23 months (from January 2026 to December 2027).
Food Preference / FSSAI: Not Applicable. This is a critical prescription medication for managing metabolic conditions, not a food item or dietary supplement. It falls strictly under the purview of national drug control authorities instead of the FSSAI, and it does not display vegetarian or non-vegetarian food preference icons.
3. Product Details: Ingredients
Each uncoated bilayered tablet contains:
Metformin Hydrochloride IP (As prolonged-release): 500 mg
Glimepiride IP: 0.5 mg
Excipients: q.s. (Quantity Sufficient)
Colour: Lake of Indigo Carmine
4. Directions: How to Use
Dosage: As directed by the Physician.
Statutory Warning Labels:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under Medical Supervision.
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: Glycomet-GP 0.5 is a fixed-dose combination oral anti-diabetic medication. It combines Metformin Hydrochloride (formulated as a prolonged-release layer to decrease glucose production and increase insulin sensitivity) with a low dose of Glimepiride (a sulfonylurea that stimulates insulin secretion). It is prescribed under strict medical supervision for glycemic management in patients diagnosed with Type 2 diabetes mellitus.
Packaging Design: The packaging features a reflective silver aluminum blister backing with standard red warning boxes to indicate its prescription-only categorization, alongside a scannable QR code for product authenticity verification.
6. Manufacturer Information
Manufactured by: USV Private Limited
Factory Address: Plot No. 538 to 540, 597 to 618, 619 to 625, GIDC Indl. Area-Savli, Taluka-Savli, Manjusar, Vadodara – 391 775.
7. Marketed By
Marketed By: USV Private Limited